References
- Oxley KS, Jackson JB, Cerutis DR. Acne (vulgaris and rosacea). 2015;1–4.
- Whitfeld M, Gunasingam N, Leow LJ, et al. Staphylococcus epidermidis: a possible role in the pustules of rosacea. J Am Acad Dermatol. 2011;64: 49–52.
- Baker SJ. Advances in the discovery of acne and rosacea treatments. ResearchGate 2007;957–968.
- Cohen AF, Tiemstra JD. Diagnosis and treatment of rosacea. J Am Board Fam Pract. 2002;15:214–217.
- Yu M, Huixian M, Mingzhu L, et al. In vitro/in vivo characterization of nanoemulsion formulation of metronidazole with improved skin targeting and anti-rosacea properties. Eur J Pharm Biopharm. 2014;1–12.
- Paolino D, Ventura CA, Nistico S, et al. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. Int J Pharm. 2002;244:21–31.
- RHR, Muller M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54:131–155.
- MULLER R, PETERSEN R, HOMMOSS A, et al. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev. 2007;59:522–530.
- Iqbal MA, Md S, Sahni JK, et al. Nanostructured lipid carriers system: recent advances in drug delivery. J Drug Target. 2012;20:813–830.
- Hagedorn-Leweke U, Lippold CB. Accumulation of sunscreens and other compounds in keratinous substrates. Eur J Pharm Biopharm. 1998;46:215–221.
- Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161–177.
- Seyfoddin A, Al-Kassas R. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir. Drug Dev Ind Pharm. 2013;39:508–519.
- Montenegro L, Campisi A, Sarpietro MG, et al. In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain. Drug Dev Ind Pharm. 2011;37:737–746.
- Patel T, Soni T, Suhagia B. Preparation and characterization of oxcarbazepine microemulsion. Egypt Pharmaceut J. 2016;15:173.
- Khullar R, Kumar D, Seth N, et al. Formulation and evaluation of mefenamic acid emulgel for topical delivery. Saudi Pharm J. 2012;20:63–67.
- Mirzaee M, Owlia P, Mehrabi MR. Comparision of the bactericidal activity of amikacin in free and liposomal formulation against Gram-negative and Gram-positive bacteria. Jundishapur J Nat Pharm Prod 2009;4:1–7.
- Rohit B, Pal KI. A method to prepare solid lipid nanoparticles with improved entrapment efficiency of hydrophilic drugs. CNANO. 2013;9:211–220.
- Muchow M, Maincent P, Muller RH. Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev Ind Pharm. 2008;34:1394–1405.
- Kasongo KW, Pardeike J, Muller RH, et al. Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers. J Pharm Sci. 2011;100:5185–5196.
- Pandey S, Das U, Patil A. Formulation and ex-vivo evaluation of metronidazole microemulsion loaded hydrogel for prevention of periodontitis. J Pharm Investig. 2014;44:225–236.
- Joshi M, Patravale V. Nanostructured lipid carrier (NLC) based gel of celecoxib. Int J Pharm. 2008;346:124–132.
- Silva AC, Santos D, Ferreira DC, et al. Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations. Pharmazie. 2009;64:177–182.
- Zhang J, Purdon CH, Smith EW. Solid lipid nanoparticles for topical drug delivery. Am J Drug Deliv. 2006;4:215–220.
- Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems – a review (part 2). Trop J Pharm Res. 2013;12:265–273.
- Singh S, Dobhal AK, Jain A, et al. Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: zidovudine. Chem Pharm Bull. 2010;58:650–655.
- Shah M, Agrawal Y. Development of ciprofloxacin HCl-based solid lipid nanoparticles using Ouzo effect: an experimental optimization and comparative study. J Dispers Sci Technol. 2013;34:37–46.
- Ghadiri M, Fatemi S, Vatanara A, et al. Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size. Int J Pharm. 2012;424:128–137.
- Pandey R, Sharma S, Khuller GK. Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis (Edinb). 2005;85:415–420.
- Shaji J, Jhadav D. Statistical development and optimization of solid dispersion self emulsifying pellets. Int J Pharma Sci Rev Res. 2010;4:156–167.
- Uprit S, Kumar Sahu R, Roy A, et al. Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia. Saudi Pharm J. 2013;21:379–385.
- Lv Q, Yu A, Xi Y, et al. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int J Pharm. 2009;372:191–198.
- Nair R, Vishnupriya K, Kumar AKS, et al. Formulation and evaluation of solid lipid nanoparticles of water soluble drug: isoniazid. J Pharma Sci Res. 2011;3:1256–1264.
- Moreno-Sastre M, Pastor M, Esquisabel A, et al. Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis. Int J Pharm. 2016;498:263–273.
- Liu D, Chen L, Jiang S, et al. Formulation and characterization of hydrophilic drug diclofenac sodium-loaded solid lipid nanoparticles based on phospholipid complexes technology. J Liposome Res. 2014;24:17–26.
- Gaba B, Fazil M, Khan S, et al. Nanostructured lipid carrier system for topical delivery of terbinafine hydrochloride. Bull Faculty Pharma Cairo Univ. 2015;53:147–159.
- Pokharkar VB, Shekhawat PB, Dhapte VV, et al. Development and optimizarion of eugenol loaded nanostructured lipid carriers for periodontal delivery. Int J Pharma Pharmaceut Sci. 2011;3:138–143.
- Bansal K, Rawat MK, Jain A, et al. Development of satranidazole mucoadhesive gel for the treatment of periodontitis. AAPS PharmSciTech. 2009;10:716–723.
- Vohra T, Kaur I, Heer H, et al. Nanolipid carrier-based thermoreversible gel for localized delivery of docetaxel to breast cancer. Cancer Nano. 2013;4:1–12.
- Nagaich U, Gulati N. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization. Drug Deliv Transl Res. 2016;6:289–298.
- Monica AS, Gautami J. Design and evaluation of topical hydrogel formulation of diclofenac sodium for improved therapy. Int J Pharma Sci Res. 2014;5:1973–1980.
- WavikarVavia PP. Nanolipidgel for enhanced skin deposition and improved antifungal activity. AAPS PharmSciTech. 2013;14:222–233.
- Madan J, Dua K, Khude P. Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery. Int J Pharma Investig. 2014;4:60.
- Kumari S, Pandita D, Poonia N, et al. Topical delivery of an anti-acne drug: characterization and ex vivo evaluation. PNT. 2015;3:122–133.
- Maia CS, Mehnert W, Schafer-Korting M. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int J Pharmaceut. 2000;196:165–167.
- Levison ME, Levison JH. Pharmacokinetics and pharmacodynamics of antibacterial agents. Infect Dis Clin North Am. 2009;23:791–815.
- Cortesi R, Valacchi G, Muresan XM, et al. Nanostructured lipid carriers (NLC) for the delivery of natural molecules with antimicrobial activity: production, characterisation and in vitro studies. J Microencapsul. 2017;34:63–72.
- Shazley GA. Ciprofloxacin controlled-solid lipid nanoparticles: characterization, in vitro release, and antibacterial activity assessment. BioMed Res J. 2017;2017:1–9.